CD40L-CD40 interaction avidity as coronary artery disease predictive factor

Authors

  • Linda Rosita Clinical Pathology Departement, Faculty of Medicine, Univeristas Islam Indonesia
  • Erlina Marfianti Internal Medicine Departement, Faculty of Medicine, Univeristas Islam Indonesia
  • Ninda Devita Clinical Pathology Departement, Faculty of Medicine, Univeristas Islam Indonesia
  • Adika Zhulhi Arjana Department of clinical Pathology and Laboratory Medicine, Faculty of Medicine, Univeristas Gadjah Mada, Yogyakarta, Indonesia

DOI:

https://doi.org/10.3329/bjms.v20i4.54137

Keywords:

CAD; CD40L; atherosclerosis

Abstract

Background: Coronary artery disease (CAD) can occur due to atherosclerosis in coronary arteries. Platelet agreement plays an important role in the pathophysiology of CAD. CD40L is a surface antigen on activated platelets. CD40L will bind to CD40 which is expressed by macrophages and endothelials then this activation results in reduced thickness and stability of atherosclerotic plaque and then thrombus appears. Thrombus ultimately inhibits blood flow to the coronary arteries. Proper measurement of these activities can describe the occurrence of CADs driven by platelets.

Objectives: Measuring the avidity of CD40L-CD40 interactions so that the relationship between CD40L activity and CAD events can be seen.

Materials and Methods: This research is non-experimental in nature and uses Case control designs. The subjects of the study were CAD patients at RSUD Dr. Soedirman Kebumen. Patients who met the inclusion and exclusion criteria were then examined and healthy patients were matched and CAD patients matched. The subject’s blood is then drawn and sent to Clinical Pathology Laboratory, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada. Blood samples were then examined using flow cytometry to determine CD40L levels. The results obtained were then analyzed by logistic regression test with Medcalc software.

Results and discussion: Twenty-six subjects participated in this study, with 13 subjects were CAD patients and 13 healthy control subjects.The percentage of platelets expressing CD62P+ CD40L+ in the CAD group was higher than in the control group (p = 0.0015). Statistical analysis with T test showed that there were significant differences in CD40-expressing platelets between the CAD group and the control group (p = 0.0029).The study conclude that the avidity of CD40L-CD40 interactions as indicated by CD40 expression is related to CAD events. CD40 expression was higher in subjects with CAD compared to controls.

Bangladesh Journal of Medical Science Vol.20(4) 2021 p.796-800

Downloads

Download data is not yet available.
Abstract
29
PDF
38

Downloads

Published

2021-06-18

How to Cite

Rosita, L., Marfianti, E., Devita, N., & Arjana, A. Z. (2021). CD40L-CD40 interaction avidity as coronary artery disease predictive factor. Bangladesh Journal of Medical Science, 20(4), 796–800. https://doi.org/10.3329/bjms.v20i4.54137

Issue

Vol. 20 No. 4 (2021)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.